Menu
Close
Our focus is to expand the range of products as well as the markets they’re available to ensure patients with vital medicines worldwide.
Company vision
Our current strategy plan to be achieved until 2030.
Adding new finished dosage forms and active pharmaceutical ingredients to our product range each year.
A part of our strategy is developing generics – both expanding into markets with the existing offer as well as adding new products to the portfolio.
Our key task is expanding into new markets. The next regions are: Western Europe, the Middle East and North Africa as well as North America.
Actively developing and maintaining our internal culture, fostering a tireless entrepreneurial spirit and “can do” attitude at all levels.